Effect of microRNA-151a-3p on ischemia-reperfusion nerve damage in rats and mechanism

Hong Chang,Zuneng Lu
DOI: https://doi.org/10.3760/cma.j.issn.1001-9030.2016.03.038
2016-01-01
Abstract:Objective To explore the specific influence mechanism in cerebral ischemia reperfusion (I/R) injury.Methods Cerebral middle cerebral artery occlusion (MCAO)-induced I/R rat model was used to observe the nerve defect,cerebral infarction area,cerebral edema and the level of apoptosis in rats.Meanwhile,cell oxygen sugar after oxygen deprivation (OGD/R) model was used to detect superoxide dismutase (SOD) and nuclear factor-κB (NF-κB) pathway.Results miR-151a-3p was higher expression in patients with cerebral ischemia reperfusion injury and MCAO rat model.The results were 6.45 ± 4.02vs.1.78 ±1.22 (P<0.05),6.22±3.13 vs.1.18±0.26 (P<0.05).ASO-miR-151a-3p can reduce rats nerve defect (2.52 ±0.92,3.34 ± 1.22 vs.0),decrease cerebral infarction area (22.51 ± 1.92,33.21 ±2.27 vs.0),alleviate cerebral edema (31.63 ±2.03,43.01 ±2.42 vs.0) and reduce apoptosis level (60.22 ± 3.02,79.28 ± 2.97 vs.9.08 ± 1.93).By detecting the molecular level related to oxidative stress in cell oxygen sugar after oxygen deprivation (OGD/R) model,we found lower malondialdehyde [MDA,(6.92±1.32),(8.53 ±1.22) vs.(4.28 ±0.93) nmol/mg] and higher SOD and glutathione (GSH) [SOD:(206.46±13.95),(104.98±10.92)vs.(288.51 ±15.02)U/mg;GSH:(3.62± 0.77),(2.18 ± 0.43) vs.(3.95 ± 0.25) mg/g].We also found that ASO-miR-151a-3p change the NF-kB passway.The mRNA and protein of IKBa were all increased (mRNA:0.72 ± 0.15,0.43 ±0.20 vs.1.00;protein:0.92 ±0.21,0.61 ±0.21 vs.1.00).However,the level of p-IKBa and p-IKKa at mRNA and protein were all decreased (p-IKBa:mRNA:5.44 ± 1.25,7.21 ±2.10 vs.1.00;protein:1.54 ±0.19,2.11 ±0.31 vs.1.00;p-IKKa:mRNA:5.78 ± 1.57,8.32 ±2.23 vs.1.00;protein:0.73 ± 0.15,1.61 ± 0.24 vs.1.00).Conclusion Our study found that miR-151 a-3p is one of the most important biological markers in I/R nerve injury of rats,and has an important significance in guiding the clinical prevention and treatment.
What problem does this paper attempt to address?